Literature DB >> 192076

Chronic lymphoproliferative disorder with unusual clinical, morphologic, ultrastructural and membrane surface marker characteristics.

R W McKenna, J Parkin, J H Kersey, K J Gajl-Peczalska, L Peterson, R D Brunning.   

Abstract

Four of 105 patients with chronic lymphocytic leukemia (CLL) manifested clinical, morphologic, ultrastructural and membrane surface marker characteristics that differed from those found in patients with typical CLL of demonstrated B-lymphocyte origin. These four patients presented with moderate increases in absolute lymphocyte counts, absolute neutropenia, polyclonal hypergammaglobulinemia and hepatosplenomegaly without lymphadenopathy. Two of them were unusually young, 19 and 25 years old, at the time of diagnosis. The proliferating lymphocytes carried receptors for sheep erythrocytes, a T-lymphocyte marker. In the three patients tested, the lymphocytes also carried Fc receptors. Ultrastructurally the lymphocytes contained cytoplasmic inclusion bodies consisting of parallel tubular arrays. The parallel tubular arrays corresponded to prominent cytoplasmic azurophilic granules on light microscopy. Parallel tubular arrays were found in less than 1 per cent of the lymphocytes in eight patients with typical B-lymphocyte CLL. The process in these four patients may be a distinctive chronic lymphoproliferative disorder originating in T lymphocytes with Fc receptors found in small numbers in the blood of normal persons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192076     DOI: 10.1016/0002-9343(77)90422-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

Review 1.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

Review 2.  Malignant lymphomas--a conceptual understanding of morphologic diversity. A review.

Authors:  R B Mann; E S Jaffe; C W Berard
Journal:  Am J Pathol       Date:  1979-01       Impact factor: 4.307

3.  Morphological heterogeneity of Leu7, Leu11 and OKM1 positive lymphocyte subsets: an ultrastructural study with the immunogold method.

Authors:  N Polli; E Matutes; D Robinson; D Catovsky
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

4.  Tubular inclusions of the circulating blood lymphocytes in the REM syndrome.

Authors:  J Daróczy; J Feldmann
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  The nature of childhood leukemia and lymphoma.

Authors:  J H Kersey; K J Gajl-Peczalska; P F Coccia; M E Nesbit
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

6.  Granular lymphocyte proliferative disorders: a multicenter study of 20 cases.

Authors:  S Woessner; E Feliu; N Villamor; M A Zarco; A Domingo; F Millá; L Florensa; M Rozman; E Abella; J Soler
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

7.  Lymphocytes with parallel tubular structures: morphologically a distinctive subpopulation.

Authors:  J W Smit; N R Blom; M van Luyn; M R Halie
Journal:  Blut       Date:  1983-06

8.  Lysosomal localisation of parallel tubular arrays in chronic lymphocytic leukaemia of T cell origin: an ultrastructural cytochemical study.

Authors:  F Capron; J Y PErrot; C Boucheix; M Reynes; V Tricottet; A Bernadou; J Diebold
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

9.  Effect of sera from patients with Hodgkin's disease on normal donor lymphocytes containing parallel tubular structures.

Authors:  J W Smit; N R Blom; M J van Luyn; G W van Imhoff; M R Halie
Journal:  Blut       Date:  1984-02

10.  Proliferation of T gamma-lymphocytes in two patients: clinical features and functional properties of the proliferating cells.

Authors:  G Schlimok; E Thiel; E P Rieber; D Huhn; H Feucht; D Renner; G Riethmüller
Journal:  Klin Wochenschr       Date:  1982-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.